Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Risk criteria for participation in the EPIC-NSW trial

From: Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial

  1. Note: According to the EPIC-NSW protocol, only people classified at high risk for HIV acquisition based on the NSW guidance on PrEP can be enrolled into the study